BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2206882)

  • 1. A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.
    Argyle JC; Hogg RJ; Pysher TJ; Silva FG; Siegler RL
    Pediatr Nephrol; 1990 Jan; 4(1):52-8. PubMed ID: 2206882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathomorphology of the kidneys in hemolytic-uremic syndrome in children].
    Khodasevich LS; Perov IuL; Nazhimov VP
    Arkh Patol; 1997; 59(3):38-44. PubMed ID: 9290024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic-uremic syndrome in children and arterial hypertension].
    Habib R; Gagnadoux MF; Broyer M
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():37-43. PubMed ID: 6794528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.
    Loirat C; Sonsino E; Varga Moreno A; Pillion G; Mercier JC; Beaufils F; Mathieu H
    Acta Paediatr Scand; 1984 Jul; 73(4):505-14. PubMed ID: 6464738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nail-patella syndrome without extra-renal lesions. A new hereditary glomerular nephropathy].
    Gubler MC; Dommergues JP; Furioli J; Foulard M; Bensman A; Boccon-Gibod L; Broyer M; Habib R
    Ann Pediatr (Paris); 1990 Feb; 37(2):78-82. PubMed ID: 2181916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomorphology of extrarenal alterations in hemolytic-uremic syndrome in children].
    Khodasevich LS; Perov IuL; Nazhimov VP
    Arkh Patol; 1997; 59(3):44-8. PubMed ID: 9290025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of hemolytic uremic syndrome in children. Importance of extrarenal involvement].
    Guyot C; Daniel MD; Roze JC; Renoult E; Dubigeon P; Buzelin F
    Arch Fr Pediatr; 1986 Apr; 43(4):253-8. PubMed ID: 3767586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney morphology in hemolytic-uremic syndrome].
    Khodasevich LS; Churkin NL
    Arkh Patol; 1988; 50(11):54-60. PubMed ID: 3233069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of so-called thrombotic microangiopathy of the kidneys (hemolytic uremic syndrome) based on early-stage morphological studies].
    John HD; Thoenes W
    Verh Dtsch Ges Pathol; 1978; 62():521. PubMed ID: 746960
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal microangiopathy of the hemolytic-uremic syndrome in childhood.
    Riella MC; George CR; Hickman RO; Striker GE; Slichter SJ; Harker L; Quadracci LJ
    Nephron; 1976; 17(3):188-203. PubMed ID: 940625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotheliotropic (hemolytic) nephroangiopathy and its various manifestation forms (thrombotic microangiopathy, primary malignant nephrosclerosis, hemolytic-uremic syndrome).
    Thoenes W; John HD
    Klin Wochenschr; 1980 Feb; 58(4):173-84. PubMed ID: 7382329
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
    Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
    Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology of the hemolytic-uremic syndrome].
    Lange HP; Hübner K
    Med Welt; 1975 Nov; 26(45):2070-3. PubMed ID: 1196095
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.
    Beaufils H; de Groc F; Gubler MC; Wechsler B; Le Hoang P; Baumelou A; Chomette G; Jacobs C
    Clin Nephrol; 1990 Oct; 34(4):157-62. PubMed ID: 2257701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postpartum hemolytic uremic syndrome: a study of three cases with a review of the literature.
    Segonds A; Louradour N; Suc JM; Orfila C
    Clin Nephrol; 1979 Nov; 12(5):229-42. PubMed ID: 389509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.